Salt Lake City-based healthcare company KindlyMD Inc. (NASDAQ: KDLY) saw its stock price soar more than 620% in pre-market trading Monday, jumping from $3.90 to $27.00, following the announcement of a landmark merger with Bitcoin-native holding company Nakamoto Holdings Inc.KindlyMD spikes to $3.90 amid Bitcoin-driven merger rally. The merger represents one of the first crossovers seen between traditional healthcare and the digital asset ecosystem to date. Nakamoto was founded by Bitcoin Magazine CEO David Bailey, who plans to turn KindlyMD into the flagship of a new Bitcoin treasury conglomerate. The merged entity's goal is to build a stockpile of Bitcoin and generate what it refers to as "Bitcoin Yield". Simply, this means it plans to collect and hold a large amount of Bitcoin and grow the amount of Bitcoin each share represents. They’ll do this by selling new stocks and borrowing money to buy more Bitcoin. The structure allows investors to directly participate in Bitcoin investments through a public company in a regulated manner. Backed by a record of over $710 million in PIPE (private investment in public equity) funding, the transaction featured over 200 investors from six continents, with some of crypto's leading names — Adam Back, Balaji Srinivasan, Jihan Wu, and Ricardo Salinas, among others — leading the deal. Among the institutions are VanEck, ParaFi, Kingsway, and Yorkville Advisors. Bailey aims to establish a financial empire centered around Bitcoin, drawing a distinction from traditional banking dynasties. “The securitization of Bitcoin will redraw the world’s economic map,” he declared, promising to have Bitcoin on every balance sheet and stock exchange. KindlyMD CEO Tim Pickett described the merger as a "strategic jump" and highlighted Nakamoto's experience with Bitcoin treasury as something that will drive long-term value. View Comments
Stock soars over 600% after surprising new strategy
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...